HP
Hikari Power Portfolio holdings
AUM
$1.2B
This Quarter Return
-10.94%
1 Year Return
+14.18%
3 Year Return
+56.59%
5 Year Return
+122.08%
10 Year Return
+191.59%
AUM
$889M
AUM Growth
+$889M
(-9.7%)
Cap. Flow
+$21.8M
Cap. Flow
% of AUM
2.45%
Top 10 Holdings %
Top 10 Hldgs %
55.95%
Holding
141
New
14
Increased
27
Reduced
13
Closed
18
Top Buys
| 1 |
Linde
LIN
|
$23.6M |
| 2 |
Bank of New York Mellon
BK
|
$12.9M |
| 3 |
GE Aerospace
GE
|
$10.8M |
| 4 |
3M
MMM
|
$5.89M |
| 5 |
Cigna
CI
|
$5.17M |
Top Sells
| 1 |
PX
Praxair Inc
PX
|
$24.3M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
$10.6M |
| 3 |
DaVita
DVA
|
$8.45M |
| 4 |
Phillips 66
PSX
|
$8.09M |
| 5 |
SGYP
Synergy Pharmaceuticals, Inc Common Stock
SGYP
|
$4.25M |
Sector Composition
| 1 | Financials | 38.62% |
| 2 | Healthcare | 19.54% |
| 3 | Industrials | 11.83% |
| 4 | Consumer Staples | 6.99% |
| 5 | Technology | 6.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Exxon Mobil
XOM
$477B
| $8.76M | 0.99% |
128,393
-2,000
| -2% | -$136K |
|
27
Colgate-Palmolive
CL
$67.7B
| $8.46M | 0.95% |
142,090
+7,500
| +6% | +$446K |
|
28
AB InBev
BUD
$116B
| $8.15M | 0.92% |
123,800
+26,850
| +28% | +$1.77M |
|
29
Vanguard S&P 500 ETF
VOO
$724B
| $7.49M | 0.84% |
32,590
+6,900
| +27% | +$1.59M |
|
30
Cisco
CSCO
$268B
| $6.85M | 0.77% |
158,000
| – | – |
|
31
Amgen
AMGN
$153B
| $6.64M | 0.75% |
34,130
| – | – |
|
32
Sanofi
SNY
$122B
| $5.95M | 0.67% |
137,040
| – | – |
|
|
33
Cigna
CI
$80.2B
| $5.45M | 0.61% |
28,697
+27,197
| +1,813% | +$5.17M |
|
|
34
DaVita
DVA
$9.72B
| $5.44M | 0.61% |
105,680
-164,260
| -61% | -$8.45M |
|
35
US Bancorp
USB
$75.5B
| $5.33M | 0.6% |
116,700
+2,000
| +2% | +$91.4K |
|
36
Vanguard Consumer Staples ETF
VDC
$7.61B
| $5.33M | 0.6% |
40,600
| – | – |
|
37
Gilead Sciences
GILD
$140B
| $5.3M | 0.6% |
84,650
| – | – |
|
38
Becton Dickinson
BDX
$54.3B
| $5.14M | 0.58% |
22,800
| – | – |
|
39
Medtronic
MDT
$118B
| $4.61M | 0.52% |
50,700
| – | – |
|
40
Biogen
BIIB
$20.8B
| $4.29M | 0.48% |
14,260
| – | – |
|
|
RDS.B
41
DELISTED
Royal Dutch Shell PLC ADS Class B
RDS.B
| $4.11M | 0.46% |
68,600
+1,600
| +2% | +$95.9K |
|
42
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$2.31B
| $4.05M | 0.46% |
184,500
+88,000
| +91% | +$1.93M |
|
43
Alphabet (Google) Class C
GOOG
$2.79T
| $4.04M | 0.45% |
3,900
| – | – |
|
44
Bristol-Myers Squibb
BMY
$96.7B
| $3.23M | 0.36% |
62,080
| – | – |
|
|
CELG
45
DELISTED
Celgene Corp
CELG
| $2.93M | 0.33% |
45,670
-500
| -1% | -$32K |
|
46
AT&T
T
$208B
| $2.77M | 0.31% |
+97,200
| New | +$2.77M |
|
47
iShares Biotechnology ETF
IBB
$5.68B
| $2.5M | 0.28% |
25,900
| – | – |
|
48
Altria Group
MO
$112B
| $2.39M | 0.27% |
48,450
| – | – |
|
|
CHL
49
DELISTED
China Mobile Limited
CHL
| $2.32M | 0.26% |
48,300
+18,500
| +62% | +$888K |
|
|
SRCL
50
DELISTED
Stericycle Inc
SRCL
| $2.18M | 0.25% |
59,400
+11,800
| +25% | +$433K |
|